Across Europe, advancements in policy, regulation, and reimbursement have set the stage for continued innovation in digital health technologies, despite challenges that demand coordinated action and advocacy.
The events of 2024—marked by regulatory milestones such as the adoption of the AI Act, the European Health Data Space (EHDS), and evolving medical device frameworks—underscore the need for streamlined processes that balance innovation with safety. In this context, the DTA has played a critical role in shaping policies, addressing barriers, and fostering collaboration among stakeholders to support the growth of DTx.
This year, DTA aims to build on these developments by advocating for reforms that enhance regulatory clarity, promote innovation, and expand patient access to life-changing digital therapies.
Read DTA’s Head of European Policy, Emilie Lopes-Fernandes’, thoughts on 2024 and 2025.